Swadesh Das, Ph.D.
Research interests: Genomic changes in the development of cancer, with a specific focus on melanoma
Lindon J. Eaves, M.A. (Oxon), Ph.D., D.Sc.
Professor Emeritus and Co-director of the Virginia Institute for Psychiatric and Behavioral Genetics
Research interests: Developmental genetic epidemiology of childhood and adolescent behavior problems in twin studies
Luni Emdad, M.B.B.S., Ph.D.
Research interests: Astrocyte elevated gene-1 (AEG-1) interacting molecules involved in cancer progression, possible cancer stemness and angiogenesis toward developing novel therapeutic strategies to inhibit cancer progression
Paul B. Fisher, M.Ph., Ph.D.
Professor and Chair
Director of the VCU Institute of Molecular Medicine
Research interests: Molecular basis of cancer and neurodegeneration; development of improved diagnostics and therapeutics for related diseases
Zheng Fu, Ph.D.
Research interests: Molecular mechanisms of cell cycle control and genome stability as they relate to carcinogenesis; development of novel, targeted cancer therapies
Mike Grotewiel, Ph.D.
Associate Professor and Director of Admissions
Research interests: Molecular-genetic basis for ethanol-related behaviors in the fruit fly genetic model, Drosophila melanogaster
Chunqing Guo, Ph.D.
Research interests: Pattern recognition scavenger receptors and their immune modulating roles in cancer immunotherapy, cellular mechanisms underlying autoimmune diseases.
Andrei Ivanov, Ph.D.
Research interests: Epithelial adherens and tight junctions and cellular mechanisms that control junctional remodeling
Joseph W. Landry, Ph.D.
Research interests: Chromatic remodeling complexes and histone modifying enzymes in the structural regulation of chromatin and ultimately gene expression; identification of small molecule therapeutics for inhibiting metastasis and immune system avoidance by tumor cells
James Lister, Ph.D.
Research interests: Specification and differentiation of pigment cells in zebrafish development, specifically defining the role of the mitfa protein in zebrafish melanocytic differentiation
Joyce A. Lloyd, Ph.D.
Professor and Vice Chair of Education
Research interests: Developmental regulation of the globin genes in erythroid cells and in the genes controlling erythroid development
Hermine H. Maes, Ph.D.
Research interests: Genetic epidemiology of juvenile psychopathology and the role of adenovirus in human obesity
Yanxia Ning, M.D., Ph.D.
Research interests: Understanding immunobiology of large heat shock proteins and pattern recognition scavenger receptors to develop novel immunotherapies for cancer and other disease
John Quillin, M.S., Ph.D.
Assistant Professor and Director of Dual Degree Program
Research interests: Cancer prevention and screening behaviors, disparities in cancer care, familial cancer risk, and risk perceptions
Devanand Sarkar, M.B.B.S., Ph.D.
Research interests: Key molecules regulating development and progression of hepatocellular carcinoma (HCC) and explores the development of therapeutic strategies to treat HCC
Rita Shiang, Ph.D.
Associate Professor and Director of Graduate Programs
Research interests: Studying the genes that cause craniosynostosis in humans and zebrafish
Judy L. Silberg, Ph.D.
Research interests: Genetic and environmental mechanisms in the development of psychopathology in children, adolescents and young adults
Mark Subler, Ph.D.
Research interests: Mammary tumorigenesis in mouse models
Xiang-Yang (Shawn) Wang, Ph.D.
Research interests: Stress responses/proteins and pattern recognition scavenger receptors, particularly their roles in immune modulation and host response, along with the development of novel immune-based cancer therapies
Jolene Windle, Ph.D.
Professor and Eminent Scholar and Director of the Massey Cancer Center Transgenic Mouse Core
Research interests: Role of oncogenes in mouse mammary tumorigenesis and the development of new transgenic mouse technologies
Timothy York, Ph.D.
Associate Professor and Assistant Director of Graduate Education
Research interests: Identification of genetic and environmental risk factors in complex disease and the use of biomarkers to elucidate disease subtypes